Daniel Zielonka
Overview
Explore the profile of Daniel Zielonka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stanislawska-Sachadyn A, Krzeminski M, Zielonka D, Krygier M, Zietkiewicz E, Slawek J, et al.
Sci Rep
. 2024 Jul;
14(1):15729.
PMID: 38977715
Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by the extension of the CAG repeats in exon 1 of the HTT gene and is transmitted in a dominant manner....
2.
3.
Kaczynska J, Sitek E, Witkowski G, Rudzinska-Bar M, Janik P, Slawek J, et al.
Neurol Neurochir Pol
. 2022 Jul;
56(4):299-307.
PMID: 35792559
Introduction: Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder. Substantial for a diagnosis of the disease are motor disorders, with chorea as a hallmark symptom. Other disease manifestations include...
4.
Mazur-Michalek I, Kowalska K, Zielonka D, Lesniczak-Staszak M, Pietras P, Szaflarski W, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628260
Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin protein. HD-related pathological remodelling has been reported in HD mouse models and HD carriers....
5.
Modrzejewska-Zielonka E, Ren M, Mlodak A, Marcinkowski J, Zielonka D
Eur Neurol
. 2022 Apr;
85(5):398-403.
PMID: 35483333
Huntington's disease (HD) is a neurodegenerative, progressive disorder conditioned by a mutation in the HTT gene. Its progression is dependent on the causative mutation extension. Caregivers of individuals affected by...
6.
Zielonka D
Neurol Neurochir Pol
. 2021 Jan;
55(1):5-7.
PMID: 33438752
Introduction: Zduńska et al. [1] present the results of a pilot study exploring changes in melatonin serum concentration in migraine patients, and the clinical implications of these changes. Clinical Reflections:...
7.
Zielonka D, Stawinska-Witoszynska B
Front Neurol
. 2020 Aug;
11:571.
PMID: 32733356
No abstract available.
8.
Zielonka D, Witkowski G, Puch E, Lesniczak M, Mazur-Michalek I, Isalan M, et al.
Front Med (Lausanne)
. 2020 Mar;
7:79.
PMID: 32219094
Huntington's disease (HD) is monogenic neurodegenerative disorder caused by CAG expansions within the Huntingtin gene (); it has a prevalence of 1 in 10,000 worldwide and is invariably fatal. Typically,...
9.
Krygier M, Kwarciany M, Wasilewska K, Pienkowski V, Krawczynska N, Zielonka D, et al.
Clin Genet
. 2018 Dec;
95(3):415-419.
PMID: 30548255
Inherited ataxias are a group of highly heterogeneous, complex neurological disorders representing a significant diagnostic challenge in clinical practice. We performed a next-generation sequencing (NGS) analysis in 10 index cases...
10.